J&J sales of OTC products plunges 40 pct in 3Q

(AP) -- U.S. sales of Johnson & Johnson's nonprescription medicines plunged 40 percent in the third quarter as an embarrassing string of product recalls hurt sales and consumer trust. That, combined with the lingering global recession and some initial price cuts from the health care overhaul, contributed to anemic earnings for the health care giant.

Read the whole article on Physorg

More from Physorg